Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation's experts explore how we got here and the potential solutions.
Nov 24, 2023
0
0
The Ebola virus can hide in the brains of monkeys that have recovered after medical treatment without causing symptoms and lead to recurrent infections, according to a study by a team I led that was published in the journal ...
Mar 16, 2022
0
22
Laboratory tests have revealed resistance in some H7N9 bird flu patients to the only available treatment, said virologists who unveiled "concerning" study results on Tuesday.
May 28, 2013
0
0
The currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19, according to a new paper involving UCL researchers.
Feb 27, 2024
0
28
(HealthDay)—For patients with rheumatoid arthritis (RA), one to three doses of tocilizumab may increase the risk of hepatitis B virus (HBV) reactivation, according to a study published online Feb. 3 in the International ...
Feb 13, 2017
0
1
(HealthDay)—A U.S. task force suggests that people at high risk for the hepatitis C virus should be screened, which includes those with a history of intravenous drug use and those who received blood transfusions before ...
Nov 26, 2012
0
0
A Spanish researcher has collaborated on a mathematical analysis, recently published in the journal Science Translational Medicine, which concludes that joint therapy to counter HIV in patients who also have hepatitis C increases ...
Dec 3, 2014
0
0
Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells. But by mimicking ...
Aug 2, 2023
0
1
Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports.
Jan 23, 2024
0
1
Adults hospitalised with H1N1 influenza during the 2009-2010 pandemic were 25% less likely to die from the disease if they were given antiviral drugs called neuraminidase inhibitors (NAIs) such as Tamiflu, according to a ...
Mar 18, 2014
0
0
